Skip to content
IP Osgoode
  • ABOUT
  • OUR TEAM
    • DIRECTOR
    • MEMBERS
    • ADVISORY BOARD
    • SPONSORS
  • IPILOGUE
    • ABOUT THE IPILOGUE
    • BLOG
      • Announcements
      • Artificial Intelligence
      • Copyright
      • Innovation
      • IP Innovation Clinic
      • IP Intensive
      • Patents
      • Privacy
      • Technology
      • Trademarks
    • IPILOGUE TEAM
    • GOWLING WLG PRIZE
    • IPIGRAM ARCHIVE
    • WRITE FOR US
  • IP INNOVATION CLINIC
    • ABOUT
    • CHATBOT
    • BECOME A CLIENT
    • CLINIC FELLOWS
    • THE IP LUNCH CLUB
    • FAQS
  • IP INTENSIVE
    • ABOUT
    • PLACEMENTS
  • RESEARCH
    • IP LAW & POLICY
    • INNOVATION
    • LAW REFORM
  • EVENTS
    • UPCOMING EVENTS
    • PAST EVENTS
  • CONTESTS & COMPETITIONS
    • 2021 Oxford International Intellectual Property Law Moot
    • IP WRITING CHALLENGE
    Home
    >
    Pharmaceutical Drugs

    Tag: Pharmaceutical Drugs

    November 12, 2020in Blogs, IP, Pharmaceutical Drugs0by Editor
    2080

    Pharmaceutical Counterfeiting: What is it and Current Issues with IP Regulations

    What is Pharmaceutical Counterfeiting? Counterfeit goods are an age-old consequence of economic markets. These consequences are especially troubling when raising concerns about the delivery of prescription medicines that the public…

    Read more
    July 15, 2020in Blogs, IP, Patents, Pharmaceutical Drugs0by Editor
    1779

    US Pharma Company, Gilead Sciences, Expands Access to COVID-19 Treatment- Experts Remain Skeptical of Long-Term Demands

    As healthcare systems around the world continue to struggle with managing the rates of transmission and mortality in patients with COVID-19, an announcement made in late April by Dr. Anthony…

    Read more
    May 21, 2015in Access to Medicines, Patents, Pharmaceutical Drugs0by Editor
    855

    Breaking the Fall Off the Patent Cliff: Can Developing Countries Help Big Pharma?

    Expiring patents are expected to contribute billions of dollars towards the loss of revenue of drug manufacturers in the years to come. To save itself from falling off the patent cliff,…

    Read more
    May 21, 2013in Copyright, Copyright Reform, European Union, IP, IP Reform, Patents, Pharmaceutical Drugs, Supreme Court of Canada, Trademarks, US, US-Canada Relations, WIPO0by Editor
    1493

    A Cautionary Kudos: Canada Moves Up on USTR IP Watch List

    Earlier this month, the United States Trade Representative (USTR) released its annual “Special 301 Report,” which evaluates the intellectual property rights (IPR) protection and enforcement of its trading partners. Over…

    Read more
    May 6, 2011in Access to Medicines, Patents, Pharmaceutical Drugs0by Editor
    757

    Canada Responds to “Emergencies” with Updated Drug Regulations

    Dan Whalen is a JD candidate at Osgoode Hall Law School. The Canada Gazette published amendments to the Patented Medicines (Notice of Compliance) Regulations, which include much-anticipated provisions for Extraordinary…

    Read more
    March 29, 2011in Access to Medicines, Cross Border Issues, Patents, Pharmaceutical Drugs0by Editor
    1242

    Election Drum Beats the Life Out of Access to Medicines Bill

    Dan Whalen is a JD candidate at Osgoode Hall Law School. Among the nearly 500 bills that died with the end of the 40th Canadian Parliament last Friday was Bill…

    Read more

    Posts navigation

    1 2 3
    Search
      Categories
      IP Osgoode
      © Osgoode Hall Law School, York University
      • Privacy & Legal
      Osgoode Hall Law School, York University
      Ignat Kaneff Building
      4700 Keele Street
      Toronto, Ontario  M3J 1P3
      Canada

      T:416.736.5030   F:416.736.5736